Tag
Panacea Biotec Limited
3 articles
Panacea Biotec Q2 FY27 Net Profit ₹10.75 Crore
Panacea Biotec reported Q2 standalone net profit of ₹10.75 crore versus loss of ₹15.64 crore YoY, with revenue up 39.5% to ₹126.69 crore.
Consolidated H1 FY27 net profit reached ₹14.11 crore compared
Panacea Biotec October 2026 Zero Shares Dematerialized
Panacea Biotec reported zero shares were dematerialized during the month of October 2026.
The total dematerialized share count remained unchanged at 6,11,09,526 shares as of October 31, 2026.
The disc
Panacea Biotec September 2026 Demat Shares Update
Panacea Biotec discloses dematerialization data for September 2026 to BSE and NSE as per SEBI Regulation 74(5).
Total demat shares increased by 1,000 to 6,11,09,526 as of September 30, 2026.
NSDL hold